Elena Castellanos Cuts Brain Inflammation 32% After Learning of 10- to 15-Fold Alzheimer’s Risk
Updated
Updated · TODAY · Jul 22
Elena Castellanos Cuts Brain Inflammation 32% After Learning of 10- to 15-Fold Alzheimer’s Risk
2 articles · Updated · TODAY · Jul 22
Summary
Nearly one year after learning she carries two APOE e4 copies, Elena Castellanos lowered a key brain inflammation marker by almost 32%, while amyloid-related measures improved 20% and an early tau marker 29%.
The 57-year-old Miami mother of three sought preventive neurology care after a 2024 genetic test showed the rare genotype, found in just 2% to 3% of people and tied to about a 10- to 15-fold higher Alzheimer’s risk.
Her regimen centered on modifiable dementia risks: a Mediterranean-style diet, cholesterol treatment, resistance and cardio exercise, stricter sleep habits to address sleep apnea, no alcohol, and regular medical, dental, eye and hearing checkups.
Blood monitoring remains costly at about $900 to $2,000 per test and is not always fully covered by insurance, underscoring how early-stage preventive dementia care can be hard to access.
Doctors say the biomarker gains do not guarantee she will avoid Alzheimer’s, but they may signal lower neurodegenerative risk and support her message that genes are not destiny.
With lifestyle in doubt and drugs restricted, what hope is there for those with the highest Alzheimer's genetic risk?
Her brain markers improved, but a new study says lifestyle fails for her genetic profile. What is the real truth?
APOE e4, Alzheimer’s, and Prevention: How Lifestyle, Biomarkers, and New Treatments Are Changing the Outlook
Overview
This report highlights how individuals carrying the APOE e4 allele face a genetic risk for Alzheimer’s disease, but effective lifestyle interventions can help reduce this risk. Lifestyle factors, such as physical activity and targeted preventive strategies, can significantly moderate the influence of APOE e4 on Alzheimer’s pathologies, especially for high-risk groups like APOE4 homozygotes. Some interventions may offer even greater benefits for APOE4 carriers compared to non-carriers. However, decisions about APOE testing and lifestyle changes should always involve informed consent and genetic counseling, as the test has limited predictive value and can have psychological impacts.